Literature DB >> 8249623

Effect of Panax notoginseng saponins on increased proliferation of cultured aortic smooth muscle cells stimulated by hypercholesterolemic serum.

S G Lin1, X L Zheng, Q Y Chen, J J Sun.   

Abstract

Panax notoginseng saponins (PNS) was extracted from a Chinese herb medicine. After preparation of cultured aortic smooth muscle cell (SMC) from primary aortic explants, the cytotoxicity of hypercholesterolemic serum (HCS) for cultured cells was determined by trypan blue exclusion test, and [3H]thymidine incorporation and cell numbers were counted at the same time. The results showed that HCS (0.5 mg cholesterol.ml-1) increased the incorporation of [3H]thymidine into cultured cells (3722 +/- 440 vs 1655 +/- 288 dpm/microgram cell proteins, P < 0.01), stimulated the proliferation of SMC [(6.5 +/- 1.5) x 10(5) vs (4.3 +/- 1.2) x 10(5) cells/plate, P < 0.01], and that high concentration HCS (final cholesterol concentration 2 mg.ml-1) was cytotoxic to the cultured cells. PNS (100 and 400 micrograms.ml-1) decreased the incorporation of [3H]thymidine into SMC in culture with or without HCS (1292 +/- 260 and 982 +/- 314 or 4111 +/- 886 and 2361 +/- 751 dpm/microgram cell protein), and inhibited the proliferation of the cultured cells [(3.3 +/- 0.7) x 10(5) and (2.9 +/- 0.7) x 10(5) or (4.7 +/- 1.4) x 10(5) and (4.1 +/- 1.2) x 10(5) cells/plate). We conclude that PNS can inhibit the proliferation of aortic SMC stimulated by HCS. These results also suggest that HCS may play an atherogenic role in the arterial wall and that PNS may prevent atherosclerosis and inhibit progression of the atherosclerotic lesions by interfering with the proliferation of arterial SMC.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8249623

Source DB:  PubMed          Journal:  Zhongguo Yao Li Xue Bao        ISSN: 0253-9756


  6 in total

1.  Notoginsenoside R1 reduces blood pressure in spontaneously hypertensive rats through a long non-coding RNA AK094457.

Authors:  Ying Yang; Peng Xi; Yuan Xie; Cuimei Zhao; Jiahong Xu; Jinfa Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 2.  Protective effects of panax notoginseng saponins on cardiovascular diseases: a comprehensive overview of experimental studies.

Authors:  Xiaochen Yang; Xingjiang Xiong; Heran Wang; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2014-07-24       Impact factor: 2.629

3.  Total Panax notoginseng saponin inhibits balloon injury-induced neointimal hyperplasia in rat carotid artery models by suppressing pERK/p38 MAPK pathways.

Authors:  Zheng Yang; Hui Zhang; Ming An; Mengni Bian; Miao Song; Xiaohua Guo; Quanli Liu; Min Qiu
Journal:  Braz J Med Biol Res       Date:  2019-12-20       Impact factor: 2.590

4.  A chinese herbal preparation containing radix salviae miltiorrhizae, radix notoginseng and borneolum syntheticum reduces circulating adhesion molecules.

Authors:  Kylie A O'Brien; Shanhong Ling; Estelle Abbas; Aozhi Dai; Jiansheng Zhang; Wen Cheng Wang; Alan Bensoussan; Ruizhi Luo; Zhi-Xin Guo; Paul A Komesaroff
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-23       Impact factor: 2.629

Review 5.  Therapeutic Potential and Cellular Mechanisms of Panax Notoginseng on Prevention of Aging and Cell Senescence-Associated Diseases.

Authors:  Haiping Zhao; Ziping Han; Guangwen Li; Sijia Zhang; Yumin Luo
Journal:  Aging Dis       Date:  2017-12-01       Impact factor: 6.745

6.  Notoginsenoside R1 inhibits vascular smooth muscle cell proliferation, migration and neointimal hyperplasia through PI3K/Akt signaling.

Authors:  Haihong Fang; Shilin Yang; Yingying Luo; Cheng Zhang; Yi Rao; Renjing Liu; Yulin Feng; Jun Yu
Journal:  Sci Rep       Date:  2018-05-15       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.